Free Trial

Trellus Health (TRLS) Competitors

GBX 0.65 0.00 (0.00%)
As of 08/1/2025

TRLS vs. IQAI, DVRG, SENS, EMIS, CRW, INS, KOO, RENX, COG, and INHC

Should you be buying Trellus Health stock or one of its competitors? The main competitors of Trellus Health include IQ-AI (IQAI), DeepVerge (DVRG), Sensyne Health (SENS), EMIS Group (EMIS), Craneware (CRW), Instem (INS), Kooth (KOO), Renalytix (RENX), Cambridge Cognition (COG), and Induction Healthcare Group (INHC). These companies are all part of the "health information services" industry.

Trellus Health vs. Its Competitors

IQ-AI (LON:IQAI) and Trellus Health (LON:TRLS) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, dividends, media sentiment, profitability, analyst recommendations, valuation, earnings and risk.

In the previous week, IQ-AI's average media sentiment score of 0.00 equaled Trellus Health'saverage media sentiment score.

Company Overall Sentiment
IQ-AI Neutral
Trellus Health Neutral

IQ-AI has higher revenue and earnings than Trellus Health.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
IQ-AI£538.19K3.30N/AN/AN/A
Trellus Health£65.83K19.09-£7.98M-£3.45-0.19

IQ-AI has a beta of 2.25, indicating that its stock price is 125% more volatile than the S&P 500. Comparatively, Trellus Health has a beta of 0.01, indicating that its stock price is 99% less volatile than the S&P 500.

19.3% of Trellus Health shares are owned by institutional investors. 66.0% of IQ-AI shares are owned by company insiders. Comparatively, 49.7% of Trellus Health shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

IQ-AI has a net margin of -77.52% compared to Trellus Health's net margin of -12,114.55%. Trellus Health's return on equity of -37.95% beat IQ-AI's return on equity.

Company Net Margins Return on Equity Return on Assets
IQ-AI-77.52% -140.75% -22.03%
Trellus Health -12,114.55%-37.95%-22.76%

Summary

IQ-AI beats Trellus Health on 5 of the 9 factors compared between the two stocks.

Get Trellus Health News Delivered to You Automatically

Sign up to receive the latest news and ratings for TRLS and its competitors with MarketBeat's FREE daily newsletter.

TRLS vs. The Competition

MetricTrellus HealthHealth Information Services IndustryMedical SectorLON Exchange
Market Cap£1.26M£222.70M£5.48B£3.03B
Dividend YieldN/A5.90%4.73%5.02%
P/E Ratio-0.19379.8128.67176.75
Price / Sales19.09223.80373.90264,362.43
Price / Cash0.7647.1435.4527.97
Price / Book0.075.088.274.53
Net Income-£7.98M-£15.55M£3.24B£5.90B
7 Day Performance-7.14%0.03%-3.69%12.58%
1 Month Performance17.97%1.48%4.33%6.10%
1 Year Performance-53.57%7.55%25.95%71.59%

Trellus Health Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
TRLS
Trellus Health
N/AGBX 0.65
flat
N/A-54.3%£1.26M£65.83K-0.1931Gap Up
IQAI
IQ-AI
N/AGBX 0.80
flat
N/A-33.3%£1.77M£538.19K-13.676Gap Up
DVRG
DeepVerge
N/AN/AN/AN/A£1.14M£12.41M-15.0073
SENS
Sensyne Health
N/AN/AN/AN/A£583K£7.81M-0.0270Gap Down
EMIS
EMIS Group
N/AN/AN/AN/A£1.23B£176.86M4,085.111,560
CRW
Craneware
1.5347 of 5 stars
GBX 2,371.67
+1.4%
GBX 2,725
+14.9%
-0.8%£1.02B£230.77M87.62734News Coverage
INS
Instem
N/AN/AN/AN/A£199.62M£61.63M5,928.57500News Coverage
KOO
Kooth
2.779 of 5 stars
GBX 181
-3.2%
GBX 456.67
+152.3%
-50.9%£66.43M£50.72M17.01478
RENX
Renalytix
N/AGBX 7.13
-1.7%
N/A-53.8%£29.54M£9.22M-0.34102Gap Down
COG
Cambridge Cognition
N/AGBX 31.50
-3.1%
N/A-41.2%£13.19M£15.64M-8.3780Gap Up
INHC
Induction Healthcare Group
N/AGBX 9.75
flat
N/A-8.0%£9.00M£12.57M-1.7674

Related Companies and Tools


This page (LON:TRLS) was last updated on 8/2/2025 by MarketBeat.com Staff
From Our Partners